CagriSema (Cagrilintide B and Semaglutide I)

Phase 2

19%

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

Upcoming Catalysts

Aug 21

NOVO-B.COPhase 2Phase 2

CagriSema (Cagrilintide B and Semaglutide I) Phase 2 Results Expected

CagriSema (Cagrilintide B and Semaglutide I) • Diabetes Mellitus, Type 2

Drug Information

Target Indication

Diabetes Mellitus, Type 2

Clinical Trial

Last updated: 12/5/2025